Biopharmaceutical company developing precision therapies for autoimmune and inflammatory diseases by targeting metabolic pathways in immune cells
Biopharmaceutical company developing precision therapies for autoimmune and inflammatory diseases by targeting metabolic pathways in immune cells. Its preclinical work includes MALT1 inhibitors and use of metabolic signatures to identify patient subpopulations.